Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
This study has been completed.
Study NCT00129181 Information provided by Institute for Neurodegenerative Disorders
First Received: August 9, 2005 Last Updated: August 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson Disease
Parkinsonian Syndrome
Additional conditions recognized in this trial
Parkinsonian Disorders
Syndrome
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Disease
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Pathologic Processes
Interventions listed in this trial
cabergoline
carbidopa/levodopa
DATscan and SPECT imaging
Additional drug interventions recognized in this trial
Carbidopa
Levodopa
Sinemet
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Dyskinesia Agents
Antineoplastic Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Enzyme Inhibitors
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Institute for Neurodegenerative Disorders
Pfizer
GE Healthcare
Back to top of Main Content
